# Applied Polymer Systems, Inc. d/b/a APS Pharmaco - Inspection Records

Source: https://www.keypedia.com/companies/applied-polymer-systems-inc-dba-aps-pharmaco/ee563dc8-1b2f-4616-97c1-5d2a94f7e8c6

> Inspection records and compliance data for Applied Polymer Systems, Inc. d/b/a APS Pharmaco in Lindenhurst, New York. Access full analysis and detailed observations.

---

## Details

- Name: Applied Polymer Systems, Inc. d/b/a APS Pharmaco
- FEI Number: 3004309648
- City: Lindenhurst
- State: New York
- Country Name: United States
- Address Line 1: 200 Bangor St
- Zip Code: 11757

## Related Documents

- [FDA Inspection 892398 - Applied Polymer Systems, Inc. d/b/a APS Pharmaco - 2014-08-22](https://www.keypedia.com/records/fda_inspections/applied-polymer-systems-inc-dba-aps-pharmaco/cb0a2ccc-b610-432f-9866-d8eb0da9ddd5) — classification: Official Action Indicated (OAI), source: FDA, date: August 22, 2014
- [FDA Inspection 892398 - Applied Polymer Systems, Inc. d/b/a APS Pharmaco - 2014-08-22](https://www.keypedia.com/records/fda_inspections/applied-polymer-systems-inc-dba-aps-pharmaco/43e92807-4cad-4676-a8cf-7f3ad6505ac6) — classification: Official Action Indicated (OAI), source: FDA, date: August 22, 2014
- [FDA Inspection 822462 - Applied Polymer Systems, Inc. d/b/a APS Pharmaco - 2013-03-14](https://www.keypedia.com/records/fda_inspections/applied-polymer-systems-inc-dba-aps-pharmaco/00d8ee9a-c5d6-4358-a17b-d877a56c7744) — classification: Official Action Indicated (OAI), source: FDA, date: March 14, 2013
- [FDA Inspection 822462 - Applied Polymer Systems, Inc. d/b/a APS Pharmaco - 2013-03-14](https://www.keypedia.com/records/fda_inspections/applied-polymer-systems-inc-dba-aps-pharmaco/f844c9df-bbde-4133-89f3-b4728185ac80) — classification: Official Action Indicated (OAI), source: FDA, date: March 14, 2013
- [WARNING_LETTER - Applied Polymer Systems, Inc. d/b/a APS Pharmaco - 2012-05-14](https://www.keypedia.com/records/warning_letter/applied-polymer-systems-inc-dba-aps-pharmaco/c016d254-75a6-4517-984c-ef7aaf952135) — source: FDA, date: May 14, 2012
- [FDA Inspection 784144 - Applied Polymer Systems, Inc. d/b/a APS Pharmaco - 2012-05-14](https://www.keypedia.com/records/fda_inspections/applied-polymer-systems-inc-dba-aps-pharmaco/a590eaaa-8a1d-4245-b8e4-316c2c4dad91) — classification: Official Action Indicated (OAI), source: FDA, date: May 14, 2012
- [FDA Inspection 784144 - Applied Polymer Systems, Inc. d/b/a APS Pharmaco - 2012-05-14](https://www.keypedia.com/records/fda_inspections/applied-polymer-systems-inc-dba-aps-pharmaco/2465f11a-66f5-4337-a8bc-e91c25f3ef53) — classification: Official Action Indicated (OAI), source: FDA, date: May 14, 2012

## Related Companies

- [Philips Respironics, Inc.](https://www.keypedia.com/companies/philips-respironics-inc/03ceee46-7a72-4590-8bc4-8033e1503cf3)
- [Prolacta Bioscience Inc](https://www.keypedia.com/companies/prolacta-bioscience-inc/fafc52a9-8c2a-4c2a-9889-e42779d7c654)
- [Reading Hospital](https://www.keypedia.com/companies/reading-hospital/06325159-9820-479a-ba2e-0f47aaa24d60)
- [Dermarite Industries, LLC.](https://www.keypedia.com/companies/dermarite-industries-llc/72e65a9b-c9c7-44e1-a73a-fd807ffb77d3)
- [Pedicraft, Inc.](https://www.keypedia.com/companies/pedicraft-inc/348fce14-ecf0-487a-9b55-1d1d07357e2a)
- [Nutra Solutions USA, Inc.](https://www.keypedia.com/companies/nutra-solutions-usa-inc/c3b931f1-cf3d-4550-b715-a5e8554a01da)
- [Abbott Vascular](https://www.keypedia.com/companies/abbott-vascular/745759b5-fe3d-4e6e-a507-d84e0ed39f35)
- [Ceragroup Industries Inc](https://www.keypedia.com/companies/ceragroup-industries-inc/3f9fa477-b335-4ef0-8997-adf1495976a3)
- [Purdue Pharma L.P.](https://www.keypedia.com/companies/purdue-pharma-lp/12a191f7-7216-4b7c-aa90-a6e20688a346)
- [Biomerieux Inc](https://www.keypedia.com/companies/biomerieux-inc/4ca56fd6-0bcf-4144-8cb6-60511d8260b4)

## Related Officers

- [Program Director](https://www.keypedia.com/people/ronald-m-pace/a79d2af4-650e-4220-8de1-92bbd284457d)